Expression Table for this CRE
| CNhs13076 | Smooth Muscle Cells - Umbilical Vein, donor3 | 18.0 |
| CNhs14417 | 293SLAM rinderpest infection, 24hr, biol_rep2 | 14.0 |
| SRX6586245 | CNhi10328_THP-1_Non-treatment (DMSO)-48h_rep5 | 11.9 |
| SRX6586244 | CNhi10328_THP-1_Non-treatment (DMSO)-48h_rep4 | 11.7 |
| SRX9760364 | skeletal muscle_6_h_after_exercise (Individual 3) | 10.7 |
| SRX9760360 | skeletal muscle_prior_exercise (Individual 3) | 9.9 |
| SRX9760352 | skeletal muscle_1_h_after_exercise (Individual 1) | 9.7 |
| SRX9760356 | skeletal muscle_2_min_after_exercise (Individual 2) | 9.6 |
| SRX9760368 | skeletal muscle_6_h_after_exercise (Individual 7) | 9.4 |
| CNhs14080 | locus coeruleus, newborn, donor10223 | 9.4 |
| SRX6586243 | CNhi10328_THP-1_Non-treatment (DMSO)-48h_rep3 | 8.5 |
| SRX9760358 | skeletal muscle_3_h_after_exercise (Individual 2) | 8.4 |
| SRX9760348 | skeletal muscle_prior_exercise (Individual 7) | 8.1 |
| CNhs12327 | epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3 | 7.9 |
| SRX9760357 | skeletal muscle_1_h_after_exercise (Individual 2) | 7.6 |
| SRX9760350 | skeletal muscle_1_h_after_exercise (Individual 7) | 7.4 |
| SRX9760372 | skeletal muscle_3_h_after_exercise (Individual 8) | 7.3 |
| SRX6586240 | CNhi10328_THP-1_Atrovastatin-30 uM-48h_rep1 | 7.3 |
| CNhs12832 | H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18) | 6.7 |
| SRX6586241 | CNhi10328_THP-1_Atrovastatin-30 uM-48h_rep2 | 6.6 |
| SRX9760354 | skeletal muscle_6_h_after_exercise (Individual 1) | 6.5 |
| CNhs14078 | amygdala, newborn, donor10223 | 6.3 |
| SRX6586242 | CNhi10328_THP-1_Atrovastatin-30 uM-48h_rep3 | 6.2 |
| SRX9760344 | skeletal muscle_2_min_after_exercise (Individual 6) | 6.1 |
| CNhs13437 | cerebrospinal fluid, donor2 | 6.0 |
| CNhs14482 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1 | 6.0 |
| SRX9760343 | skeletal muscle_prior_exercise (Individual 6) | 5.8 |
| SRX6586360 | CNhi10331_MCF-7_siRNA (HSS104864) treatment-48h_rep3 | 5.6 |
| CNhs13925 | Mast cell, expanded and stimulated, donor5 | 5.5 |
| CNhs13073 | mesothelioma cell line:Mero-95 | 5.4 |
| SRX6586366 | CNhi10369_MCF-7_siRNA-negative control-48h_rep2 | 5.4 |
| CNhs12394 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13) | 5.3 |
| CNhs12837 | H9 Embryonic Stem cells, biol_rep3 (H9ES-3) | 5.0 |
| SRX9760365 | skeletal muscle_prior_exercise (Individual 4) | 4.9 |
| SRX9760353 | skeletal muscle_3_h_after_exercise (Individual 1) | 4.9 |
| CNhs14058 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3 | 4.9 |
| CNhs13854 | Myoblast differentiation to myotubes, day10, control donor1 | 4.9 |
| SRX6586362 | CNhi10331_MCF-7_siRNA (HSS179267) treatment-48h_rep2 | 4.8 |
| SRX6586335 | CNhi10317_MCF-7_Non-treatment (DMSO)-48h_rep5 | 4.8 |
| SRX9760363 | skeletal muscle_3_h_after_exercise (Individual 3) | 4.8 |
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 4.7 |
| CNhs14082 | globus pallidus, newborn, donor10223 | 4.6 |
| SRX6586334 | CNhi10317_MCF-7_Non-treatment (DMSO)-48h_rep4 | 4.5 |
| SRX9760355 | skeletal muscle_prior_exercise (Individual 2) | 4.5 |
| SRX9760362 | skeletal muscle_1_h_after_exercise (Individual 3) | 4.4 |
| SRX9760361 | skeletal muscle_2_min_after_exercise (Individual 3) | 4.4 |
| CNhs12705 | MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3 | 4.3 |
| SRX9760351 | skeletal muscle_3_h_after_exercise (Individual 7) | 4.3 |
| SRX6586333 | CNhi10317_MCF-7_Non-treatment (DMSO)-48h_rep3 | 4.2 |
| SRX6586367 | CNhi10369_MCF-7_siRNA-negative control-48h_rep3 | 4.1 |